To boost the country’s manufacturing industry, the Chinese government is providing tax breaks to companies for upgrading their equipment and scaling up R&D. The tax breaks are especially aimed at small- and medium-sized enterprises. Tax reductions will be based on the value of new R&D equipment and facilities purchased after January 1 of this year […]
A World Bank and Elsevier report shows the development of research in sub-Sahran Africa (SSA) from 2003 to 2012 by three regions: West and Central Africa, East Africa, and Southern Africa (excluding South Africa). All regions more than doubled their peer-reviewed publications, with their combined share of worldwide output growing from 0.44% to 0.72%. The […]
Since 1998, the US FDA has approved 3 drugs for brain cancer, 10 for lung cancer and 7 for melanoma. However, for brain cancer, 75 drugs failed in development, 167 therapies for lung cancer failed in clinical trials, and 96 drugs for melanoma failed in development. Presently, in the US, 47 new therapies for brain […]
According to the US EPA’s Office of Inspector General (OIG), approximately 300 chemicals considered by the Resource Conservation and Recovery Act to be hazardous are unregulated. The Clean Water Act allows the EPA to regulate any substances, but the agency applies the rule to only 126 priority chemicals. Although industrial polluters are required to report […]
For the second quarter, revenues for IBO’s Lab Equipment/Consumables Index grew 4.1%, 4.0% excluding currency, to $4,278 million. Operating profit for the Index rose 7.6% to $794 million. Based on continuing operations, operating margin gained 50 basis points to 16.5% of sales. Second quarter sales benefited from delayed orders in the first quarter due to […]
A summary of biopharmaceutical approvals in the US and UK from January 2010 to July 2014 showed that 54 products were approved. Drugs new to the market accounted for 59% of the therapies (32), with the remaining biologics being biosimilars, reformulated and me-too drugs, and products that previously had been approved elsewhere. Of the 32 […]
Hong Kong 10/9/14; Singapore 10/9/14—Techcomp has agreed to acquire from Bruker the assets related to Bruker’s GC and single-quadrupole GC/MS businesses, including inventories, intellectual property, trademark, licenses and other assets, for $13.5 million. The net book value of the tangible assets is $14 million. Techcomp stated that the acquisition will allow it to expand its […]
Pleasanton, CA 10/9/14—Roche has acquired exclusive rights to target-discovery company AbVitro’s primer-extension–based target-enrichment (PETE) technology and associated patent applications. Financial details were not disclosed. PETE technology will be used to support Roche’s next-generation sequencing (NGS) directly from blood or other biological samples. The technology will be incorporated into the Sequencing Unit’s R&D pipeline to support […]
Chelmsford, MA 10/1/14—Brooks Automation, a provider of automation and cryogenic solutions, has acquired UK-based FluidX for $16 million. FluidX is a supplier of biological-sample storage tubes and complementary benchtop instruments. In 2013, FluidX generated $10 million in sales. “FluidX is an important building block for Brooks Life Science Systems, bringing state-of-the-art biological-sample storage consumables into […]
Franklin Lakes, NJ 10/13/14—Becton, Dickinson and Company (BD) has acquired GenCell Biosystems for an undisclosed amount. Founded in 2011 and based in Ireland with an office in the US, GenCell provides technology for biological-analysis protocols, including library preparation for next-generation sequencing (NGS) and genotyping for agricultural applications. “We are excited with the GenCell Biosystems acquisition […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
